Imaging Diagnostic Systems, Inc., (OTCBB: IMDS), a pioneer in
laser optical breast imaging, announced today that the Australian
Government Department of Health and Ageing Therapeutic Goods
Administration has approved the CT Laser Mammography (CTLM®) system for
inclusion on the Australian Register of Therapeutic Goods (ARTG). The
Therapeutic Goods Administration (TGA) must approve the inclusion of all
medical devices on the Register before devices can be sold in Australia.
“We are
very pleased with the work that our distributor has been doing in this
market and anticipate many new developments from this approval.”
“Gaining approval in Australia is an important step for us. It enables
us to reach the Australian market and to perhaps influence related
markets,” stated Deborah O’Brien, IDSI’s Senior Vice President. “We are
very pleased with the work that our distributor has been doing in this
market and anticipate many new developments from this approval.”
Approval was obtained through the efforts of Jainsons Pty Ltd., the
official distributor of the CTLM system in Australia. Jainsons will now
work to introduce the system to the Australian market through commercial
and clinical exhibitions, advertising, and the development of clinical
studies and partnerships.
“Australia TGA approval will open the well-informed and educated
Australian market to the CTLM system,” commented Dr. Mukesh Jain,
Chairman and CEO of Jainsons. “Once CTLM technology has been introduced
and accepted in Australia, the possibility of penetrating Asian
countries also emerges, as approval in Australia is of international
significance. TGA approval for the CTLM system is indeed a great
achievement for IDSI and Jainsons, one that will open new doors for the
marketing of this technology.”